Abstract
Background
Untreated Cushing disease historically has a high mortality rate, but the long-term survival of patients with Cushing disease after transsphenoidal surgery has not been reported.Objective
To determine long-term mortality rate in patients who are treated for Cushing disease with current management techniques.Design
Retrospective case series.Setting
Tertiary care center.Patients
161 patients (32 men and 129 women; mean age, 38 years) who were treated for Cushing disease between 1978 and 1996.Intervention
Transsphenoidal adenomectomy and as-needed adjunctive therapy.Measurement
Record review with follow-up interview.Results
The cure rate for patients with microadenomas who had no previous therapy was 90% (123 of 137). No perioperative deaths occurred (0 of 193 procedures [95% CI, 0.0% to 1.9%]). Follow-up data (mean, 8.7 years) were obtained for 99% of patients (159 of 161). Six patients died. The 5- and 10-year survival rates were 99% (CI, 97% to 100%) and 93% (CI, 88% to 99%), respectively. Survival was similar to that seen in an age- and sex-matched sample that was based on U.S. population data (standardized mortality ratio, 0.98 [CI, 0.44 to 2.2]; P > 0.2).Conclusion
Survival of patients treated for Cushing disease with current management techniques between 1978 and 1996 was better than the poor survival historically associated with this disorder.Full text links
Read article at publisher's site: https://doi.org/10.7326/0003-4819-130-10-199905180-00015
Citations & impact
Impact metrics
Citations of article over time
Article citations
Cushing's Disease Presenting with Functional Neurological (Conversion) Disorder.
Case Rep Psychiatry, 2023:1662271, 08 Mar 2023
Cited by: 0 articles | PMID: 36938346 | PMCID: PMC10017209
Reoperation for Recurrent and Persistent Cushing's Disease without Visible MRI Findings.
J Clin Med, 11(22):6848, 20 Nov 2022
Cited by: 1 article | PMID: 36431325 | PMCID: PMC9699622
MRI-negative Cushing's Disease: Management Strategy and Outcomes in 15 Cases Utilizing a Pure Endoscopic Endonasal Approach.
BMC Endocr Disord, 22(1):154, 09 Jun 2022
Cited by: 3 articles | PMID: 35676664 | PMCID: PMC9178868
The Effect of Endogenous Cushing Syndrome on All-cause and Cause-specific Mortality.
J Clin Endocrinol Metab, 107(8):2377-2388, 01 Jul 2022
Cited by: 17 articles | PMID: 35486378 | PMCID: PMC9282270
Review Free full text in Europe PMC
Descriptive Epidemiology and Survival Analysis of Prolactinomas and Cushing's Disease in Korea.
Endocrinol Metab (Seoul), 36(3):688-696, 28 Jun 2021
Cited by: 3 articles | PMID: 34218648 | PMCID: PMC8258328
Go to all (113) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Transsphenoidal surgery in Cushing disease: 10 years of experience in 34 consecutive cases.
J Neurosurg, 100(4):634-638, 01 Apr 2004
Cited by: 31 articles | PMID: 15070117
Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test.
J Neurosurg, 98(5):967-973, 01 May 2003
Cited by: 96 articles | PMID: 12744355
The clinical response to treatment in adult Cushing's syndrome following remission of hypercortisolaemia.
Postgrad Med J, 61(713):205-211, 01 Mar 1985
Cited by: 8 articles | PMID: 3983055 | PMCID: PMC2418188
Epidemiology and follow-up of Cushing's disease.
Ann Endocrinol (Paris), 62(2):168-172, 01 Apr 2001
Cited by: 19 articles | PMID: 11353889
Review